| Literature DB >> 29317521 |
Ha Yin Lee1, Yoko Itahana1, Stefan Schuechner2, Masahiro Fukuda3, H Shawn Je3, Egon Ogris2, David M Virshup1,4,5, Koji Itahana6.
Abstract
Cancer cells increase glucose metabolism to support aerobic glycolysis. However, only some cancer cells are acutely sensitive to glucose withdrawal, and the underlying mechanism of this selective sensitivity is unclear. We showed that glucose deprivation initiates a cell death pathway in cancer cells that is dependent on the kinase RIPK1. Glucose withdrawal triggered rapid plasma membrane depolarization and an influx of extracellular calcium into the cell through the L-type calcium channel Cav1.3 (CACNA1D), followed by activation of the kinase CAMK1. CAMK1 and the demethylase PPME1 were required for the subsequent demethylation and inactivation of the catalytic subunit of the phosphatase PP2A (PP2Ac) and the phosphorylation of RIPK1. Plasma membrane depolarization, PP2Ac demethylation, and cell death were prevented by glucose and, unexpectedly, by its nonmetabolizable analog 2-deoxy-d-glucose (2-DG), a glycolytic inhibitor. These findings reveal a previously unknown function of glucose as a signaling molecule that protects cells from death induced by plasma membrane depolarization, independently of its role in glycolysis. Components of this cancer cell death pathway represent potential therapeutic targets against cancer.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29317521 DOI: 10.1126/scisignal.aam7893
Source DB: PubMed Journal: Sci Signal ISSN: 1945-0877 Impact factor: 8.192